Biotech traded in positive territory all day on Wednesday, closing near the highs for the day. The Centient Biotech 200 gained 23.78 (.71%) to close at 3386.84. Following approval of their MS drug yesterday, Biogen-Idec and Elan were the volume leaders. We look at their achievement, plus the biggest winners and losers on the day.
